Abstract
Over-expression and abnormal intracellular location of the product of the oncogene c-myc in colonic dysplasia and neoplasia may be related to alterations in epigenetic mechanisms controlling the functioning of this gene. We have investigated the methylation patterns of the c-myc oncogene in human colorectal tissue representing various stages of dysplasia and neoplasia, including metastasis to liver, omentum and lymph node. Comparison of normal and neoplastic tissues from the same patient showed a decrease in methylation in a specific CCGG site in the third exon of c-myc through the progression from normal via dysplastic to neoplastic and metastatic tissue. Quantitative analysis revealed that in colonic adenocarcinomas an average of 66.1% and in metastatic deposits 83.1% of the myc gene DNA was hypomethylated at this site, as compared to a value of 9.2% in normal colonic mucosa. Adenomatous polyps showed an average value of 50.5% and hyperplastic polyps, 24.8%. The results suggest that partial hypomethylation of the c-myc gene third exon is associated with cell proliferation, and that deregulation of proliferation may be linked to the high levels of hypomethylation, presumably involving both copies of the gene in some cells, which occur at a relatively early stage in neoplastic progression.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharrard, R., Royds, J., Rogers, S. et al. Patterns of methylation of the c-myc gene in human colorectal cancer progression. Br J Cancer 65, 667–672 (1992). https://doi.org/10.1038/bjc.1992.142
Issue Date:
DOI: https://doi.org/10.1038/bjc.1992.142
This article is cited by
-
Significant position of C-myc in colorectal cancer: a promising therapeutic target
Clinical and Translational Oncology (2022)
-
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer
Clinical Epigenetics (2021)
-
The transition from primary colorectal cancer to isolated peritoneal malignancy is associated with an increased tumour mutational burden
Scientific Reports (2020)
-
Disruption of the Molecular Circadian Clock and Cancer: An Epigenetic Link
Biochemical Genetics (2020)
-
Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas
Nature Communications (2016)